蛋白质降解剂进入新的靶点领域。 - Suppr

Suppr

超能文献

Protein degraders push into novel target space.

作者信息

Mullard Asher

出版信息

Nat Rev Drug Discov. 2024 Nov;23(11):799-802. doi: 10.1038/d41573-024-00170-9.

DOI:10.1038/d41573-024-00170-9

PMID:39402425

Abstract

摘要

相似文献

Protein degraders push into novel target space.

Nat Rev Drug Discov. 2024 Nov;23(11):799-802. doi: 10.1038/d41573-024-00170-9.

Protein degraders enter the clinic - a new approach to cancer therapy.

Nat Rev Clin Oncol. 2023 Apr;20(4):265-278. doi: 10.1038/s41571-023-00736-3. Epub 2023 Feb 13.

Emerging mechanisms of targeted protein degradation by molecular glues.

Methods Cell Biol. 2022;169:1-26. doi: 10.1016/bs.mcb.2022.01.001. Epub 2022 Mar 31.

Industry Perspective on the Pharmacokinetic and Absorption, Distribution, Metabolism, and Excretion Characterization of Heterobifunctional Protein Degraders.

Drug Metab Dispos. 2023 Jul;51(7):792-803. doi: 10.1124/dmd.122.001154. Epub 2023 Apr 11.

RAS degraders: The new frontier for RAS-driven cancers.

Mol Ther. 2023 Jul 5;31(7):1904-1919. doi: 10.1016/j.ymthe.2023.03.017. Epub 2023 Mar 21.

Cross-Linking Profiling of Molecular Glue Degrader-Induced E3 Ligase Interactome to Expand Target Space.

Angew Chem Int Ed Engl. 2025 May 26;64(22):e202505053. doi: 10.1002/anie.202505053. Epub 2025 Apr 7.

Fundamental aspects of DMPK optimization of targeted protein degraders.

Drug Discov Today. 2020 Jun;25(6):969-982. doi: 10.1016/j.drudis.2020.03.012. Epub 2020 Apr 13.

Haven't got a glue: Protein surface variation for the design of molecular glue degraders.

Cell Chem Biol. 2021 Jul 15;28(7):1032-1047. doi: 10.1016/j.chembiol.2021.04.009. Epub 2021 Apr 29.

Towards the Rational Design of Monovalent Degraders: Lessons Learnt from Cyclin K Degraders.

Chimia (Aarau). 2025 Mar 26;79(3):162-166. doi: 10.2533/chimia.2025.162.

BRD4 Levels Determine the Response of Human Lung Cancer Cells to BET Degraders That Potently Induce Apoptosis through Suppression of Mcl-1.

Cancer Res. 2020 Jun 1;80(11):2380-2393. doi: 10.1158/0008-5472.CAN-19-3674. Epub 2020 Mar 10.

引用本文的文献

A manifesto for Alzheimer's disease drug discovery in the era of disease-modifying therapies.

Mol Neurodegener. 2025 Aug 6;20(1):88. doi: 10.1186/s13024-025-00872-7.

Transcription Factors and Methods for the Pharmacological Correction of Their Activity.

Int J Mol Sci. 2025 Jul 2;26(13):6394. doi: 10.3390/ijms26136394.

The changing landscape of medicinal chemistry optimization.

Nat Rev Drug Discov. 2025 Jul 7. doi: 10.1038/s41573-025-01225-1.

E3Docker: a docking server for potential E3 binder discovery.

Nucleic Acids Res. 2025 May 8. doi: 10.1093/nar/gkaf391.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Protein degraders push into novel target space.

Nat Rev Drug Discov. 2024 Nov;23(11):799-802. doi: 10.1038/d41573-024-00170-9.

Protein degraders enter the clinic - a new approach to cancer therapy.

Nat Rev Clin Oncol. 2023 Apr;20(4):265-278. doi: 10.1038/s41571-023-00736-3. Epub 2023 Feb 13.

Emerging mechanisms of targeted protein degradation by molecular glues.

Methods Cell Biol. 2022;169:1-26. doi: 10.1016/bs.mcb.2022.01.001. Epub 2022 Mar 31.

Industry Perspective on the Pharmacokinetic and Absorption, Distribution, Metabolism, and Excretion Characterization of Heterobifunctional Protein Degraders.

Drug Metab Dispos. 2023 Jul;51(7):792-803. doi: 10.1124/dmd.122.001154. Epub 2023 Apr 11.

RAS degraders: The new frontier for RAS-driven cancers.

Mol Ther. 2023 Jul 5;31(7):1904-1919. doi: 10.1016/j.ymthe.2023.03.017. Epub 2023 Mar 21.

Cross-Linking Profiling of Molecular Glue Degrader-Induced E3 Ligase Interactome to Expand Target Space.

Angew Chem Int Ed Engl. 2025 May 26;64(22):e202505053. doi: 10.1002/anie.202505053. Epub 2025 Apr 7.

Fundamental aspects of DMPK optimization of targeted protein degraders.

Drug Discov Today. 2020 Jun;25(6):969-982. doi: 10.1016/j.drudis.2020.03.012. Epub 2020 Apr 13.

Haven't got a glue: Protein surface variation for the design of molecular glue degraders.

Cell Chem Biol. 2021 Jul 15;28(7):1032-1047. doi: 10.1016/j.chembiol.2021.04.009. Epub 2021 Apr 29.

Towards the Rational Design of Monovalent Degraders: Lessons Learnt from Cyclin K Degraders.

Chimia (Aarau). 2025 Mar 26;79(3):162-166. doi: 10.2533/chimia.2025.162.

BRD4 Levels Determine the Response of Human Lung Cancer Cells to BET Degraders That Potently Induce Apoptosis through Suppression of Mcl-1.

Cancer Res. 2020 Jun 1;80(11):2380-2393. doi: 10.1158/0008-5472.CAN-19-3674. Epub 2020 Mar 10.

引用本文的文献

A manifesto for Alzheimer's disease drug discovery in the era of disease-modifying therapies.

Mol Neurodegener. 2025 Aug 6;20(1):88. doi: 10.1186/s13024-025-00872-7.

Transcription Factors and Methods for the Pharmacological Correction of Their Activity.

Int J Mol Sci. 2025 Jul 2;26(13):6394. doi: 10.3390/ijms26136394.

The changing landscape of medicinal chemistry optimization.

Nat Rev Drug Discov. 2025 Jul 7. doi: 10.1038/s41573-025-01225-1.

E3Docker: a docking server for potential E3 binder discovery.

Nucleic Acids Res. 2025 May 8. doi: 10.1093/nar/gkaf391.